1. Home
  2. LIVE vs MAIA Comparison

LIVE vs MAIA Comparison

Compare LIVE & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Live Ventures Incorporated

LIVE

Live Ventures Incorporated

HOLD

Current Price

$12.42

Market Cap

30.3M

ML Signal

HOLD

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

HOLD

Current Price

$1.38

Market Cap

44.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIVE
MAIA
Founded
1968
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.3M
44.9M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
LIVE
MAIA
Price
$12.42
$1.38
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
7.2K
521.9K
Earning Date
12-11-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.46
N/A
Revenue
$443,794,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$26.32
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.25
$0.87
52 Week High
$25.88
$2.74

Technical Indicators

Market Signals
Indicator
LIVE
MAIA
Relative Strength Index (RSI) 51.01 62.77
Support Level $9.05 $1.07
Resistance Level $12.49 $1.25
Average True Range (ATR) 1.14 0.12
MACD 0.48 0.05
Stochastic Oscillator 71.58 81.36

Price Performance

Historical Comparison
LIVE
MAIA

About LIVE Live Ventures Incorporated

Live Ventures Inc is a holding company for diversified businesses. It is focused on acquiring and operating profitable companies in various industries. The company operates in the business segments of Retail Entertainment which includes direct sales of entertainment and appliance products and services, Flooring Manufacturing, Steel Manufacturing, which includes the sale of steel plates, ground flat stock, and drill rods, and Corporate and Other. It derives key revenue from the Flooring Manufacturing segment which includes the manufacturing of carpets and rugs, yarn products, as well as a reseller of hard surface flooring products. Geographically the activities are carried out throughout the United States.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

Share on Social Networks: